Literature DB >> 28991822

Respiratory Viruses in Invasively Ventilated Critically Ill Patients-A Prospective Multicenter Observational Study.

Frank van Someren Gréve1,2, Nicole P Juffermans1, Lieuwe D J Bos1, Jan M Binnekade1, Annemarije Braber3, Olaf L Cremer4, Evert de Jonge5, Richard Molenkamp2, David S Y Ong4,6, Sjoerd P H Rebers2, Angelique M E Spoelstra-de Man7, Koenraad F van der Sluijs1, Peter E Spronk3, Kirsten D Verheul2, Monique C de Waard7, Rob B P de Wilde5, Tineke Winters1, Menno D de Jong2, Marcus J Schultz1.   

Abstract

OBJECTIVES: The presence of respiratory viruses and the association with outcomes were assessed in invasively ventilated ICU patients, stratified by admission diagnosis.
DESIGN: Prospective observational study.
SETTING: Five ICUs in the Netherlands. PATIENTS: Between September 1, 2013, and April 30, 2014, 1,407 acutely admitted and invasively ventilated patients were included.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Nasopharyngeal swabs and tracheobronchial aspirates were collected upon intubation and tested for 14 respiratory viruses. Out of 1,407 patients, 156 were admitted because of a severe acute respiratory infection and 1,251 for other reasons (non-severe acute respiratory infection). Respiratory viruses were detected in 28.8% of severe acute respiratory infection patients and 17.0% in non-severe acute respiratory infection (p < 0.001). In one third, viruses were exclusively detected in tracheobronchial aspirates. Rhinovirus and human metapneumovirus were more prevalent in severe acute respiratory infection patients (9.6% and 2.6% vs 4.5 and 0.2%; p = 0.006 and p < 0.001). In both groups, there were no associations between the presence of viruses and the number of ICU-free days at day 28, crude mortality, and mortality in multivariate regression analyses.
CONCLUSIONS: Respiratory viruses are frequently detected in acutely admitted and invasively ventilated patients. Rhinovirus and human metapneumovirus are more frequently found in severe acute respiratory infection patients. Detection of respiratory viruses is not associated with worse clinically relevant outcomes in the studied cohort of patients.

Entities:  

Mesh:

Year:  2018        PMID: 28991822     DOI: 10.1097/CCM.0000000000002752

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

Review 1.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

2.  Specific Viral Etiologies Are Associated With Outcomes in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Anna L Roberts; Julia S Sammons; Peter M Mourani; Neal J Thomas; Nadir Yehya
Journal:  Pediatr Crit Care Med       Date:  2019-09       Impact factor: 3.624

3.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

4.  Respiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia.

Authors:  Michael Klompas; Peter B Imrey; Pei-Chun Yu; Chanu Rhee; Abhishek Deshpande; Sarah Haessler; Marya D Zilberberg; Michael B Rothberg
Journal:  Infect Control Hosp Epidemiol       Date:  2020-12-01       Impact factor: 6.520

Review 5.  Testing for Respiratory Viruses in Adults With Severe Lower Respiratory Infection.

Authors:  James M Walter; Richard G Wunderink
Journal:  Chest       Date:  2018-06-14       Impact factor: 9.410

6.  What's New in Critical Illness and Injury Science? Antibiotics in critical care: Therapeutic toolbox.

Authors:  Anisha Mathur
Journal:  Int J Crit Illn Inj Sci       Date:  2019-09-30

7.  Parechovirus A prevalence in adults in The Netherlands.

Authors:  Lieke Brouwer; Katja C Wolthers; Dasja Pajkrt
Journal:  Arch Virol       Date:  2020-02-14       Impact factor: 2.574

Review 8.  Ventilator-associated pneumonia in adults: a narrative review.

Authors:  Laurent Papazian; Michael Klompas; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2020-03-10       Impact factor: 17.440

9.  Respiratory virus-associated infections in HIV-infected adults admitted to the intensive care unit for acute respiratory failure: a 6-year bicenter retrospective study (HIV-VIR study).

Authors:  Alexandre Elabbadi; Jérémie Pichon; Benoit Visseaux; Aurélie Schnuriger; Lila Bouadma; Quentin Philippot; Juliette Patrier; Vincent Labbé; Stéphane Ruckly; Muriel Fartoukh; Jean-François Timsit; Guillaume Voiriot
Journal:  Ann Intensive Care       Date:  2020-09-14       Impact factor: 6.925

10.  Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis?

Authors:  Claire N Shappell; Michael Klompas; Chanu Rhee
Journal:  Crit Care Med       Date:  2020-12       Impact factor: 9.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.